AMPOULES AND SYRINGES MARKET ANALYSIS

Ampoules are small vials that contain solution or powder form drug for injecting it into the body through the intravenous route. It basically stores the drug and produced form plastic such as PVC and PE. Glass is also used to produce ampoules and are sealed tightly in order to prevent the penetration of any foreign particles. The syringe is a type of medical device that looks like a simple pump. It is used to deliver drugs inside the body by using the solution present in the ampoules. It has a needle attached to it which is pierced to deliver the drug through the intravenous route. The needle is made up of plastic and disposable materials.

The global ampoules & syringes market is estimated to be valued at US$ 6,469.7 million in 2021 and is expected to exhibit a CAGR of 6.4 % over the forecast period (2021-2028).

Recent Developments:

In August 2021, Indian Vaccine manufacturer Serum Institute of India has bought out the Indian partner in the SCHOTT Kaisha joint venture for an undisclosed amount. This development is aimed at helping Serum Institute to tie up its back-end supplies in the wake of global demands, as the JV makes pharma packaging products, including vials, syringes, ampoules and cartridges used to package life-saving medications.

In May 2021, Hindustan Syringes & Medical Devices Ltd. Have announced to recruit 500 people to increase syringe production capacity to reach our target of 100 crore AD syringes production capacity.

In October 2020, Hindustan Syringes & Medical Devices Ltd. has sent its first shipment of 56 million pieces of auto disable syringes to Covax facility for the continuous supply demand activity for safe and effective vaccine production

North America held dominant position in the global ampoules & syringes market in 2020, accounting for 37.4% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1. Global Ampoules & Syringes Market Value (US$ Mn), by Region, 2020

To learn more about this report, request sample copy

Drivers:

Growth in the geriatric population with various chronic diseases coupled with the improving medical facility is prime factors fueling the market growth of ampoules & syringes. According to the Coherent Market Insights analysis, the population size is also projected to increase in number by 56% between 2015 and 2030. By 2050 the geriatric population will nearly double in size and likely reach 2.1 billion.

Improvement in the injectable drug delivery devices is expected to propel the market growth of the ampoules & syringes. Manufacturers are introducing user-friendly injectable which can be used at home or near the patients. This enhances the patient experience, in turn, raising the demand for self-administrable devices. This factor is expected to augment the market growth of the ampoules & syringes over the forecast period. 

Market Opportunities

Growth in the pharmaceutical industry due to the rising production of pharmaceutical products is expected to provide potential growth opportunities to the market of the ampoules & syringes. According to the IQVIA Institute for Human Data Science, the global market for pharmaceuticals reached $1.2 trillion in 2018, up to $100 billion from 2017. Hence, growth in the pharmaceutical industry will favor the market growth in the near future.

Rising spending on the health care industry especially in the North America region is projected to foster the market growth of the ampoules & syringes. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2018, reaching $3.6 trillion or $11,172 per person. Moreover, health spending accounted for 17.7 percent as a share of the nation's Gross Domestic Product.

Market Trends/Key Takeaways

Continuous product innovation by major players is expected to accelerate the market growth of the forecast period. For instance, in July 2017, Gerresheimer has expanded its product portfolio of pre-fillable syringes made of glass and plastics with the introduction of the innovative, integrated, and passive syringe safety solution. The new safety solution is fully compatible with Gerresheimer’s well-established RTF (ready-to-fill) syringe portfolio.

The introduction of disposable syringes by major players is a major trend observed in the market and this is expected to accelerate the market growth of the ampoules & syringes. For instance, in October 2019, BD (Becton, Dickinson, and Company) has launched the BD Intevi 1mL two-step disposable autoinjector, a device combining autoinjector and pre-fillable syringe in one integrated system. It is a two-step push-on-skin device for effectively and safely injects a variety of drugs of different viscosities up to 35cP and different fill volumes up to 1mL.

Figure 2. Global Ampoules & Syringes Market Share, By Product Type, 2020

To learn more about this report, request sample copy

Key Takeaways of the Graph:

• The Syringes segment held dominant position in the market and accounted for 62.3% share in the global ampoules & syringes market in 2020. The segment is expected to reach US$ 6,308.7 million in 2028.
• Rising number of surgical procedures across the globe which require syringes as one of the main equipment or device, and increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases are some of the major factors to drive the syringes segment market growth during the forecast period.

Market Restraints

High cost associated with temperature-controlled packaging for temperature-sensitive drugs is expected to hinder the market growth of the ampoules & syringes. In order to maintain specified temperature and conditions of the drug companies required maintenance of various machinery associated with the process which increases the overall cost of the process. This is expected to hamper the market growth.

Increasing cases of needle stick injuries is another major factor expected to restrict the use of syringes which in turn is projected to hinder the market growth of the ampoules & syringes in the near future.

Competitive Section:

Company Names 

1. Schott AG
2. Gerresheimer AG
3. Becton, Dickinson, and Company 
4. West Pharmaceutical Services, Inc.
5. Nipro Corporation
6. Vetter Pharma International GmbH 
7. Stevanato Group
8. TOPAS Advanced Polymers
9. JSR CORPORATION.
10. Baxter International Inc.
11. Terumo Corporation
12. B. Braun Melsungen AG
13. Unilife Corporation
14. Ypsomed Holding AG
15. Medtronic
16. Zeon Corporation

Recent Developments

• In December 2020, BD (Becton, Dickinson and Company) announced its plans to invest around $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) across its six global manufacturing locations and add a new manufacturing facility in Europe